Your browser is no longer supported. Please, upgrade your browser.
DVAX Dynavax Technologies Corporation monthly Stock Chart
DVAX [NASD]
Dynavax Technologies Corporation
Index- P/E- EPS (ttm)-2.48 Insider Own0.41% Shs Outstand61.25M Perf Week-7.13%
Market Cap1.28B Forward P/E- EPS next Y-1.54 Insider Trans0.00% Shs Float59.50M Perf Month-0.95%
Income-102.00M PEG- EPS next Q-0.47 Inst Own61.90% Short Float12.51% Perf Quarter118.32%
Sales7.70M P/S165.85 EPS this Y10.10% Inst Trans-0.23% Short Ratio2.59 Perf Half Y272.32%
Book/sh2.83 P/B7.37 EPS next Y5.50% ROA-79.90% Target Price24.75 Perf Year101.45%
Cash/sh2.07 P/C10.06 EPS next 5Y- ROE-93.70% 52W Range3.20 - 24.45 Perf YTD427.85%
Dividend- P/FCF- EPS past 5Y5.50% ROI-124.10% 52W High-14.72% Beta1.45
Dividend %- Quick Ratio11.90 Sales past 5Y-12.60% Gross Margin- 52W Low551.56% ATR1.12
Employees251 Current Ratio11.90 Sales Q/Q-96.20% Oper. Margin- RSI (14)47.36 Volatility7.10% 4.96%
OptionableYes Debt/Eq0.00 EPS Q/Q45.70% Profit Margin- Rel Volume0.45 Prev Close20.40
ShortableNo LT Debt/Eq0.00 EarningsNov 06 BMO Payout- Avg Volume2.87M Price20.85
Recom1.80 SMA20-5.57% SMA505.83% SMA200110.24% Volume1,278,138 Change2.21%
Sep-25-17Reiterated RBC Capital Mkts Outperform $26 → $28
Sep-15-17Initiated Cantor Fitzgerald Overweight $24
Jul-31-17Upgrade RBC Capital Mkts Sector Perform → Outperform $7 → $26
Jul-31-17Upgrade JP Morgan Neutral → Overweight
May-09-17Reiterated RBC Capital Mkts Sector Perform $6 → $7
Apr-28-16Downgrade RBC Capital Mkts Outperform → Sector Perform $48 → $17
Apr-27-16Downgrade JP Morgan Overweight → Neutral
Nov-30-15Initiated RBC Capital Mkts Outperform $48
Nov-25-13Upgrade MLV & Co Hold → Buy $1.50 → $5
Feb-25-13Downgrade MLV & Co Buy → Hold
Nov-16-12Reiterated MLV & Co Buy $10 → $7.50
Jan-04-12Initiated MLV & Co Buy $8
Nov-09-10Reiterated Wedbush Outperform $6 → $8
Nov-08-10Initiated Jefferies Buy $4
May-13-10Upgrade Wedbush Neutral → Outperform $2.60 → $6
Mar-20-09Initiated Wedbush Morgan Buy $1.20
Oct-22-08Downgrade Oppenheimer Outperform → Perform
May-19-08Reiterated Susquehanna Financial Positive $7 → $5
May-19-08Downgrade Bear Stearns Outperform → Peer Perform
Mar-18-08Downgrade Merriman Curhan Ford Buy → Neutral
Oct-19-17 08:27AM  Dynavax Technologies Corporation (DVAX) Announces Dosing of First Subject in Phase 1b Study of DV281 SmarterAnalyst
06:30AM  Dynavax Initiates Clinical Trial in Non-Small Cell Lung Cancer with a Novel Inhaled TLR9 Agonist in Combination with Anti-PD-1 Therapy Marketwired
Oct-17-17 08:10AM  Today's Research Reports on Stocks to Watch: Dynavax and Exelixis ACCESSWIRE -5.04%
Oct-12-17 10:26AM  ETFs with exposure to Dynavax Technologies Corp. : October 12, 2017 Capital Cube
Oct-05-17 12:24PM  Two Techs And Two Biotechs Breaking Out Forbes
11:10AM  Harry Boxers four stocks that are breaking out this week MarketWatch
Oct-04-17 07:40AM  Featured Company News - Dynavax Considers Strategic Options for its Hepatitis B Vaccine ACCESSWIRE
Oct-03-17 08:00AM  Today's Research Reports on Trending Tickers: Dynavax Technologies and Valeant Pharmaceuticals ACCESSWIRE
Oct-02-17 09:45AM  Deals of the day-Mergers and acquisitions Reuters +8.14%
09:11AM  Why Dynavax Technologies Corporation Stock Is Rising Today Motley Fool
Sep-30-17 02:00PM  These 4 Small Biotechs Have Big Upcoming Catalysts TheStreet.com
08:07AM  Should You Have Dynavax Technologies Corporations (DVAX) In Your Portfolio? Simply Wall St.
Sep-29-17 11:37PM  Immunotherapy developer Dynavax explores options for Hepatitis B drug - sources Reuters
Sep-27-17 10:27AM  ETFs with exposure to Dynavax Technologies Corp. : September 27, 2017 Capital Cube
Sep-15-17 05:23PM  ETFs with exposure to Dynavax Technologies Corp. : September 15, 2017 Capital Cube
08:27AM  3 Biotech Stocks I'd Buy Right Now Motley Fool
Sep-14-17 08:43AM  Are Options Traders Betting on a Big Move in Dynavax (DVAX) Stock? Zacks
Sep-13-17 07:39PM  3 Biotech Stocks That Have Already Quadrupled in 2017 Motley Fool
09:43AM  Dynavax: Buy On Weakness Ahead Of November's PDUFA Date Benzinga
Sep-12-17 11:37AM  Is It Time To Buy Dynavax Technologies Corporation (DVAX)? Simply Wall St.
Sep-06-17 12:42PM  Harry Boxer: 4 breakout charts to watch MarketWatch
Sep-05-17 05:53PM  Federman & Sherwood Announces Settlement in Dynavax Shareholder Derivative Action Business Wire
06:00AM  Dynavax to Present at Upcoming Investor Conferences Marketwired
Sep-04-17 04:42PM  Here Are 3 Strong Biotech Stocks In 2017 Forbes
Sep-01-17 08:17PM  Robbins Arroyo LLP Announces Settlement in Dynavax Technologies Corporation (DVAX) Shareholder Derivative Action Business Wire
Aug-31-17 06:11PM  ETFs with exposure to Dynavax Technologies Corp. : August 31, 2017 Capital Cube
Aug-24-17 11:31AM  Dynavax Technologies Corp. :DVAX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017 Capital Cube +6.17%
Aug-15-17 04:01PM  Dynavax Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock Marketwired
Aug-09-17 08:00PM  Dynavax Prices Public Offering of Common Stock Marketwired -7.77%
08:46AM  Biotech Stock Roundup: Q2 Earnings from Regeneron, Kite & More, FibroGen Up on IPF Data Zacks
Aug-08-17 06:05PM  5 Top Stocks for August Motley Fool
04:05PM  Dynavax Announces Proposed Public Offering of Common Stock Marketwired
08:37AM  Dynavax Technologies (DVAX) Catches Eye: Stock Adds 11.2% in Session Zacks
Aug-04-17 08:00AM  Today's Research Reports on Trending Tickers: Dynavax Technologies and Valeant Pharmaceuticals ACCESSWIRE
Aug-03-17 04:14PM  Dynavax shares plummet 11% on news of delay for FDA decision about its hepatitis B vaccine MarketWatch +5.92%
04:00PM  Dynavax Provides U.S. Regulatory Update on HEPLISAV-B(TM) Following FDA Advisory Committee Meeting Marketwired
01:27PM  These two biotech stocks are breaking out MarketWatch
11:33AM  Dynavax Technologies Corporation (DVAX) Has the Market Buzzing with Heplisav Approval at the Finish Line, Exelixis, Inc. (EXEL) Refractory RCC Drug Going Strong in its Launch SmarterAnalyst
11:05AM  Here's Why Dynavax Technologies Corporation Stock Shot Up 64.2% in July Motley Fool
Aug-02-17 10:58PM  Dynavax Technologies reports 2Q loss Associated Press +5.59%
07:01PM  Cramer's lightning round: It's amazing what speculative s... CNBC Videos
06:50PM  Cramer's lightning round: It's amazing what speculative stocks can do CNBC
08:32AM  Biotech Stock Roundup: Q2 Earnings from Gilead, CELG & More, Dynavax Up on Panel Vote Zacks
06:00AM  Dynavax Reports Second Quarter 2017 Financial Results Marketwired
Aug-01-17 10:54AM  Company News For August 1, 2017 Zacks
09:20AM  August PDUFA Dates: Biotech Investors Stay Tuned To A Month Of Plenty Benzinga
08:00AM  Today's Research Reports on Stocks to Watch: InVivo Therapeutics Holdings and Dynavax Technologies ACCESSWIRE
07:29AM  Key FDA Events to Watch Out for in Aug 2017 Zacks
07:00AM  Featured Company News Dynavax Announces FDA Advisory Committee Vote in Favor of HEPLISAV-B(TM) ACCESSWIRE
06:54AM  Dynavax stock skyrockets 72% after rollercoaster ride toward vaccine approval MarketWatch
Jul-31-17 04:30PM  Why Dynavax Technologies, Alliance Holdings, and Sohu.com Jumped Today Motley Fool +71.35%
04:11PM  Why Clovis, Regeneron Are Leading A Biotech Deluge Today Investor's Business Daily
02:58PM  US STOCKS-Dow hits record high while tech cedes ground Reuters
02:50PM  William Blair Boosts Price Target for Dynavax Technologies Corporation (DVAX) as VRBPAC Panel Gives Thumbs Up to Heplisav SmarterAnalyst
02:24PM  Dynavax (DVAX) Shares Jump 75% after FDA Committee Approval Zacks
12:23PM  Biotech pops more than 70% after FDA panel greenlights hepatitis B vaccine CNBC
11:06AM  Story Stocks from Briefing.com Briefing.com
10:59AM  Dynavax Technologies Corporation (DVAX) Celebrates FDA AdCom Recommendation; Cowen Cheers SmarterAnalyst
10:05AM  US STOCKS-Wall St opens higher, Dow rises to record high Reuters
08:56AM  US STOCKS-Wall St set to open higher on earnings optimism Reuters
08:18AM  Dynavax shares skyrocket nearly 90% after FDA advisory committee vote MarketWatch
08:15AM  Up 81.6%: Is Dynavax Technologies Corporation Stock Still a Buy? Motley Fool
Jul-28-17 05:21PM  Data supports safety of Dynavax hepatitis B vaccine -U.S. FDA panel Reuters
04:59PM  Dynavax Gets 12-1 FDA Vote For Hepatitis B Vaccine Benzinga
04:35PM  Dynavax Announces FDA Advisory Committee Vote in Favor of HEPLISAV-B(TM) Marketwired
03:58PM  Data supports safety of Dynavax hepatitis B vaccine -U.S. FDA panel Reuters
Jul-26-17 12:33PM  Why Dynavax Technologies Corporation Stock Is Slumping Today Motley Fool +5.05%
12:32PM  Dynavax hepatitis B vaccine works; raises safety issues -FDA Reuters
08:40AM  More deaths with Dynavax vaccine but overall rate low - FDA Reuters
Jul-25-17 08:00AM  Todays Research Reports on Trending Tickers: Genocea Biosciences Inc. and Dynavax Technologies Corporation Accesswire -7.04%
Jul-21-17 12:57PM  William Blair Bullish on Biotech: Sarepta Therapeutics Inc (SRPT), Dynavax Technologies Corporation (DVAX), and Exelixis, Inc. (EXEL) SmarterAnalyst
Jul-11-17 08:41AM  Options Traders Expect Huge Moves in Dynavax Technologies (DVAX) Stock Zacks
Jun-30-17 02:53PM  ETFs with exposure to Dynavax Technologies Corp. : June 30, 2017 Capital Cube
Jun-28-17 04:22PM  5 Biotech Stocks With Major Catalysts in July Motley Fool
Jun-24-17 11:42AM  3 Stocks That Could Double Your Money Motley Fool
Jun-23-17 03:48PM  Lifshitz & Miller LLP Files Amended Shareholder Derivative Lawsuit on Behalf of Dynavax Technologies Corporation PR Newswire
Jun-21-17 08:30AM  Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance Business Wire +5.65%
08:20AM  Dynavax Technologies (DVAX) Catches Eye: Stock Gains 6.6% Zacks
Jun-06-17 08:15AM  Dynavax (DVAX) Looks Good: Stock Gains 16.9% in Session Zacks
08:00AM  Today's Research Reports on Stocks to Watch: Dynavax Technologies and Gigamon Accesswire
Jun-05-17 02:13PM  ETFs with exposure to Dynavax Technologies Corp. : June 5, 2017 Capital Cube +16.95%
12:17PM  Why Dynavax Technologies Corporation Stock Soared Today Motley Fool
Jun-02-17 04:01PM  Dynavax Presents Updated Data for SD-101 in Combination with KEYTRUDA(R) (pembrolizumab) Highlighting an ORR in 7 out of 7 Patients Naive to an Anti-PD-1 or Anti-PD-L1 Therapy Marketwired
May-31-17 07:06AM  3 Growth Stocks for Savvy Investors Motley Fool
May-30-17 08:00AM  Today's Research Reports on Stocks to Watch: AEterna Zentaris and Dynavax Technologies Accesswire
May-19-17 06:00AM  Dynavax to Present Data on SD-101 in Combination with KEYTRUDA(R) at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting Marketwired
May-11-17 04:31PM  ETFs with exposure to Dynavax Technologies Corp. : May 11, 2017 Capital Cube
May-10-17 10:35AM  Dynavax Technologies Corp. :DVAX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017 Capital Cube
May-08-17 06:06AM  Dynavax Technologies reports 1Q loss Associated Press
06:00AM  Dynavax Reports First Quarter 2017 Financial Results Marketwired
Apr-21-17 02:53PM  ETFs with exposure to Dynavax Technologies Corp. : April 21, 2017 Capital Cube
Apr-07-17 04:22PM  ETFs with exposure to Dynavax Technologies Corp. : April 7, 2017 Capital Cube
09:55AM  William Blair Assigns 70% Probability of Approval to Dynavax's Heplisav Investopedia
Apr-03-17 05:05PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
12:43PM  What Dynavax Technologies Holders Need to Consider Heading Into the Heplisav-B PDUFA GuruFocus.com
10:05AM  Why Dynavax Technologies Corporation Stock Briefly Spiked Today Motley Fool
10:05AM  Why Dynavax Technologies Corporation Stock Briefly Spiked Today at Motley Fool
06:00AM  Dynavax Announces FDA Advisory Committee Meeting to Review HEPLISAV-B Marketwired
Mar-27-17 03:55PM  ETFs with exposure to Dynavax Technologies Corp. : March 27, 2017 Capital Cube
03:55PM  ETFs with exposure to Dynavax Technologies Corp. : March 27, 2017
Dynavax Technologies Corporation, a clinical-stage immunotherapy company, focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation. Its product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of hepatitis B and as a disease modifying therapy for asthma. The company's lead product candidates include HEPLISAV-B, an investigational adult hepatitis B vaccine, which is in Phase III clinical trials; and SD-101, an investigational cancer immunotherapeutic that is in Phase I/II studies. Its product candidates also comprise AZD1419, which is in Phase II clinical trial for the treatment of asthma; DV230F that is in preclinical stage for the treatment of liver tumors; and DV1001, a TLR 7&8 agonist, which is in preclinical stage for the treatment of for multiple malignancies, as well as DV281 for the treatment of non-small cell lung cancer. It has collaboration and license agreements with AstraZeneca AB to develop AZD1419 for the treatment of asthma; and Merck & Co. to develop SD-101 for varios immuno-oncology therapies. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is headquartered in Berkeley, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
OSTRACH MICHAEL SSenior Vice PresidentMar 14Option Exercise0.0010,000018,772Mar 15 08:43 PM
Janssen RobertVice PresidentMar 14Option Exercise0.0010,000027,048Mar 15 08:40 PM
Novack David FSenior Vice PresidentMar 14Option Exercise0.0020,000022,121Mar 15 08:37 PM
Johnson David LouisVice PresidentFeb 05Option Exercise0.004,68804,688Feb 07 06:45 PM
Gray EddieCEO and DirectorFeb 04Option Exercise0.0050,000055,250Feb 07 06:47 PM
Janssen RobertVice PresidentJan 24Buy4.046,00024,24012,048Jan 26 07:11 PM